Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Crossref DOI link: https://doi.org/10.1007/s40487-016-0028-9
Published Online: 2016-08-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Francescon, Sara http://orcid.org/0000-0001-8042-7773
Fornasier, Giulia
Baldo, Paolo